News Release Article from
Archived - CNSC renews Nordion (Canada) Inc.'s nuclear substance processing facility operating licence
September 29, 2015 – Ottawa
Following a public hearing, the Canadian Nuclear Safety Commission (CNSC) announced today its decision to renew Nordion (Canada) Inc.’s (Nordion) nuclear substance processing facility operating licence. The licence will be valid from November 1, 2015 until October 31, 2025.
In making its decision, the Commission considered information presented at an August 19, 2015 public hearing in Ottawa, ON. During the public hearing, the Commission received and considered submissions from Nordion and 14 intervenors, as well as CNSC staff’s recommendations.
With this decision, the Commission approves Nordion’s revised financial guarantee. The Commission also directs CNSC staff to provide annual reporting on the performance of the Nordion facility as part of the CNSC’s Regulatory Oversight Report for Uranium and Nuclear Substance Processing Facilities in Canada. CNSC staff shall present these reports at public Commission proceedings, where requests to intervene from members of the public can be filed.
The Record of Proceedings, Including Reasons for Decision is available upon request to the Commission Secretariat. It will be available, in both official languages, on the CNSC website at a later date. Transcripts of the hearing are available on the CNSC website at nuclearsafety.gc.ca, or by contacting the CNSC. The webcast of the hearing is archived on the same site for a period of 90 days.
The Canadian Nuclear Safety Commission regulates the use of nuclear energy and materials to protect health, safety, security and the environment, and to implement Canada’s international commitments on the peaceful use of nuclear energy; and to disseminate objective scientific, technical and regulatory information to the public.
- The CNSC issued Nordion a nuclear substance processing facility operating licence, valid from November 1, 2015 until October 31, 2025.
- Nordion has been located in Ottawa, ON since 1946.
- Nordion is a health science company that processes nuclear substances (radioisotopes) for medical and industrial applications.
- Nordion’s performance is reported annually in the CNSC’s Regulatory Oversight Report for Uranium and Nuclear Substance Processing Facilities in Canada.
Media and Community Relations
Canadian Nuclear Safety Commission
Search for related information by keyword
Canadian Nuclear Safety Commission Health and Safety
- Date modified: